Professor Stephen Bain meets the ICMJE criteria for authorship for this manuscript, takes responsibility for the integrity of the work as a whole, and has given final approval for the version to be published
January 3, 2025 Update: Judge Marston issued a scheduling order in the Mounjaro and GLP-1 drug litigation after manufacturers filed motions to dismiss, citing federal preemption of failure-to-warn claims
Alharbi B, Al-kuraishy HM, Al-Gareeb AI et al (2024) Role of GABA pathway in motor and non-motor symptoms in Parkinsons disease: a bidirectional circuit
GLP-1 medications are powerful and require proper medical oversight
Current Opinion in Cell Biology
Zepbound (tirzepatide) is FDA-approved for chronic weight management in adults with obesity and for adults who are overweight and have at least one related health issue, like high cholesterol or high blood pressure, as well as for treating obstructive sleep apnea in adults with obesity